At UHN, we strive to deliver Compassionate Care & Caring. Learn more about the services and supports that are available to you throughout your journey.
Our UHN programs and services are among the most advanced in the world. We have grouped our physicians,
staff, services and resources into 10 medical programs to meet the needs of our patients and help us make
the most of our resources.
At the heart of everything we do at UHN are our Healthcare Professionals. Refer a patient to one of our 12 medical programs. Learn more about the resources and opportunities available for professional growth.
University Health Network has grown to be one of the largest research and teaching hospital networks in Canada - pioneers in improving the lives of patients. Our long history of health professions education at Toronto General, Toronto Western, Princess Margaret and Toronto Rehab hospitals has consistently advanced the science of education.
University Health Network is a health care and medical research organization in
Toronto, Ontario, Canada. The scope of research and complexity of cases at UHN has made us a national and international
source for discovery, education and patient care.
Being touched by illness affects us in different ways. Many people want to give back to the community
and help others. At UHN, we welcome your contribution and offer different ways you can help so you can find one that suits you.
The Newsroom is the source for media looking for information about UHN or trying to connect with one
of our experts for an interview. It's also the place to find UHN media policies and catch up on our news stories, videos, media releases,
podcasts and more.
Recognizing patterns is a useful skill that enables us to make predictions and plan for the future.
A new study from Princess Margaret (PM) Cancer Centre suggests that protein patterns expressed by brain tumours reveal information about their aggressiveness and location. This information can be useful for disease management.
The study focused on a common form of brain tumour called meningioma, which develops in tissues that surround the brain and spinal cord.
"Predicting the behaviour of these tumours using a standard assessment of cellular features under a microscope is not always accurate," explains Dr. Phedias Diamandis, PM scientist and neuropathologist at UHN. "In some cases, tumours that are classified as less aggressive return after therapy, which is the opposite of what we would expect."
This disparity has prompted clinical researchers to explore the use of genetic information to distinguish between clinical subtypes. While mapping the genetic landscape of meningioma has provided insight into the biology of the disease, our understanding of these tumours at the protein level has been lacking.
As most therapies are designed to target proteins, understanding which proteins the tumours are most dependent on for growth and aggressiveness provides an exciting avenue to design more effective and less toxic therapies.
To address the gap, Dr. Diamandis and his team used state-of-the-art technology to profile more than over 3,000 proteins in 61 meningioma tumours. They compared protein patterns across different groups of cancers based on the aggressiveness, location, treatment type and whether the cancer returned after treatment.
They found that protein patterns differed according to the tumour's size and location within the skull, as well as its aggressiveness.
"These findings suggest that global molecular profiling of brain tumours could one day help physicians to identify aggressive cancers and to better customize treatments to individual patients," says Dr. Diamandis.
This work was supported by the Ontario Institute for Cancer Research's Ontario Molecular Pathology Network, Department of Pathology at the University Health Network the Brain Tumour Foundation of Canada, the Canadian Institutes of Health Research and The Princess Margaret Cancer Foundation.